The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the efficacy and safety of 24 weeks treatment with
theophylline plus low-dose formoterol-budesonide in subjects with bronchiectasis.
Phase:
Phase 4
Details
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University